Trauma

Fibrolamellar carcinoma (FLC) is an uncommon malignant tumour of hepatocyte origin that differs from hepatocellular carcinoma (HCC) in aetiology, demographics, condition of the affected liver, tumour markers, and prognosis.1,2 In the past, FLC was termed eosinophilic hepatocellular carcinoma with lamellar fibrosis, hepatocellular carcinoma with polygo-nal cell type and fibrous stroma, eosinophilic glassy cell hepa-toma, and fibrolamellar oncocytic hepatocellular carcinoma.2 First described by Edmondson in 1956, the distinct clinical and pathological features of FLC were not fully appreciated until 1980.2,3 If amenable, FLC, like most localised hepatic malig-nancies, is best treated by complete surgical resection.2,4-6 Positive prognostic factors include resectability, absence of lymph node metastases at presentation, normal serum live